Clinical Trials
2 trialsNCT06634875 2026-03-31
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Buzzard Pharmaceuticals
Phase 2 Recruiting
NCT04121442 2024-08-06
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors
Buzzard Pharmaceuticals
Phase 1/2 Completed